Drug Shortage Report for DILTIAZEM HYDROCHLORIDE INJECTION

Last updated on 2024-04-18 History
Report ID 221999
Drug Identification Number 02514095
Brand name DILTIAZEM HYDROCHLORIDE INJECTION
Common or Proper name Diltiazem Hydrochloride Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 5 mL vial / fiole
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-03-12
Estimated end date 2024-04-19
Actual end date 2024-04-17
Shortage status Resolved
Updated date 2024-04-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-04-18 English Compare
v8 2024-04-17 French Compare
v7 2024-04-17 French Compare
v6 2024-04-17 English Compare
v5 2024-04-17 French Compare
v4 2024-04-17 English Compare
v3 2024-03-13 English Compare
v2 2024-03-12 French Compare
v1 2024-03-12 English Compare

Showing 1 to 9 of 9